medicine for non hodgkin lymphoma - Page 8 of 11

BEMUSTIN 100MG INJ

BEMUSTIN 100MG INJ is a Schedule G drug. BEMUSTIN 100MG INJ is composed of: BENDAMUSTINE (100.0 MG)

ALCRIST 1MG INJ is a Schedule H drug. ALCRIST 1MG INJ is composed of: VINCRISTINE (1.0 MG)

VINCRISTINE 1MG INJ is a Schedule H drug. VINCRISTINE 1MG INJ is composed of: VINCRISTINE (1 MG)

VCR INJ is a Schedule H drug. VCR INJ is composed of: VINCRISTINE (1 MG)

REDITUX INJ is a Schedule H drug. REDITUX INJ is composed of: RITUXIMAB (10 MG/ML)

REDITUX-RA INJ is a Schedule H drug. REDITUX-RA INJ is composed of: RITUXIMAB (10 MG/ML)

MABTAS INJ is a Schedule H drug. MABTAS INJ is composed of: RITUXIMAB (10 MG/ML)

CELPLAT 50 MG INJ is a Schedule H drug. CELPLAT 50 MG INJ is composed of: CISPLATIN (50 MG)

CISPLATIN 120MG INJ is a Schedule H drug. CISPLATIN 120MG INJ is composed of: CISPLATIN (50 MG)

BENDIT INJ is a Schedule G drug. BENDIT INJ is composed of: BENDAMUSTINE (100 MG)